RedHill Biopharma annual operating expenses
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
RedHill Biopharma Operating Expenses Growth & History (RDHL)
RedHill Biopharma's operating expenses was $8.2M for fiscal 2025.
View full RedHill Biopharma company overviewRedHill Biopharma annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $8.2M | −$11.3M | −57.90% |
| 2024 | 2024-12-31 | $19.5M | $9.9M | +103.88% |
| 2023 | 2023-12-31 | $9.5M | −$61.8M | −86.61% |
| 2022 | 2022-12-31 | $71.3M | −$46.2M | −39.31% |
| 2021 | 2021-12-31 | $117.5M | $26.3M | +28.89% |
| 2020 | 2020-12-31 | $91.2M | $43.9M | +92.98% |
| 2019 | 2019-12-31 | $47.2M | $2.4M | +5.30% |
| 2018 | 2018-12-31 | $44.9M | −$9.0M | −16.71% |
| 2017 | 2017-12-31 | $53.9M | $23.2M | +75.74% |
| 2016 | 2016-12-31 | $30.6M | $8.6M | +39.26% |
| 2015 | 2015-12-31 | $22.0M | — | — |
RedHill Biopharma quarterly operating expenses
Q2.17
Q2.18
Q2.19
Q2.20
Q2.21
Q2.22
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2022 | 2022-06-30 | $18.5M | −$17.3M | −48.29% |
| Q2 2021 | 2021-06-30 | $35.8M | $16.6M | +86.34% |
| Q2 2020 | 2020-06-30 | $19.2M | $5.7M | +42.11% |
| Q2 2019 | 2019-06-30 | $13.5M | $2.3M | +20.89% |
| Q2 2018 | 2018-06-30 | $11.2M | −$2.6M | −18.68% |
| Q2 2017 | 2017-06-30 | $13.8M | — | — |
RedHill Biopharma operating expenses trends
Over the last five fiscal years, RedHill Biopharma's operating expenses decreased from $91.2M to $8.2M, a change of −$83.0M. The latest reported quarter, Q2 2022, shows $18.5M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review RedHill Biopharma source filings ↗